Vycor Medical (VYCO) Share-based Compensation (2010 - 2025)

Vycor Medical (VYCO) has 16 years of Share-based Compensation data on file, last reported at $12209.0 in Q3 2025.

• Share-based Compensation for Q3 2025 came in at $12209.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $12209.0 (down 71.43% YoY), and the FY2025 annual result was $48838.0, up 82.35% from the prior year.
• Share-based Compensation retreated to $12209.0 in Q3 2025 per VYCO's latest filing, from $18315.0 in the prior quarter.
• Over five years, Share-based Compensation peaked at $122430.0 in Q1 2021 and troughed at -$1771.0 in Q4 2022.
• A 5-year average of $37134.8 and a median of $21367.0 in 2024 frame the typical range for Share-based Compensation.
• The sharpest annual moves came in 2022 and 2024: Share-based Compensation sank 103.11% in 2022, then soared 932.95% in 2024.
• A 5-year view of Share-based Compensation shows it stood at $56996.0 in 2021, then slumped by 103.11% to -$1771.0 in 2022, then jumped by 233.48% to $2364.0 in 2023, then soared by 932.95% to $24419.0 in 2024, then plunged by 50.0% to $12209.0 in 2025.
• Business Quant data shows VYCO's Share-based Compensation at $12209.0 in Q3 2025, $18315.0 in Q1 2025, and $24419.0 in Q4 2024.